IWM
AGIO icon

IHT Wealth Management’s Agios Pharmaceuticals AGIO Stock Holding History

IHT Wealth Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-60
Closed -$4K – 1683
2017
Q4 		$4K Buy
+60
New +$3.77K ﹤0.01% 1365

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

IHT Wealth Management's AGIO Position: Q1 2018 in Review

IHT Wealth Management sold out of Agios Pharmaceuticals (AGIO) in Q1 2018, closing a stake of 60 shares — an estimated $4K sold.

IHT Wealth Management first reported a position in AGIO in Q4 2017 and held it in 1 quarter. The position peaked at $4K in Q4 2017. 198 funds tracked by Wall St. Rank hold AGIO as of Q1 2018.

  • IHT Wealth Management reported no remaining Agios Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • IHT Wealth Management sold 60 Agios Pharmaceuticals shares in Q1 2018, an estimated $4K.
  • IHT Wealth Management first reported a position in Agios Pharmaceuticals in Q4 2017 and held it in 1 quarter.
  • IHT Wealth Management's Agios Pharmaceuticals position peaked at $4K in Q4 2017.
  • 198 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2018.

Based on IHT Wealth Management's 13F filing for Q1 2018, filed 15 May 2018.